Clinical Trial

Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 28, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to assess the safety and efficacy of cryopreserved AURN001 in patients with corneal edema secondary to endothelial dysfunction.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-10-04; most recent amendment 2025-01-27.
Trial Details
NCT Number NCT06630169
Lead Sponsor Aurion Biotech
Conditions Corneal Edema
Enrollment 25 participants
Start Date 2024-09-16
Primary Completion 2025-10 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2025-01-28